Breaking News Instant updates and real-time market news.

NSTG

NanoString

$15.30

0.03 (0.20%)

, LRCX

Lam Research

$155.75

-0.09 (-0.06%)

16:15
08/08/17
08/08
16:15
08/08/17
16:15

Lam Research to develop NanoString's proprietary Hyb & Seq platform

NanoString Technologies (NSTG) and Lam Research Corporation (LRCX) announced a strategic collaboration to develop NanoString's proprietary Hyb & Seq next generation sequencing platform. Under the terms of the collaboration, Lam will provide up to $50M of funding intended to cover the costs of development and regulatory approval over a development period expected to last approximately three years, as well as advanced engineering and technical support. Lam will receive a warrant to purchase 1M shares of NanoString common stock at $16.75 per share, as well as a royalty on all products developed under the collaboration. NanoString retains all rights to commercialize the resulting Hyb & Seq products, and the parties will share ownership rights in jointly developed intellectual property.

NSTG

NanoString

$15.30

0.03 (0.20%)

LRCX

Lam Research

$155.75

-0.09 (-0.06%)

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 10

    Aug

  • 11

    Aug

NSTG NanoString
$15.30

0.03 (0.20%)

12/06/16
BARD
12/06/16
NO CHANGE
Target $26
BARD
Outperform
NanoString a top growth idea, says Baird
Baird analyst Catherine Ramsay is recommending NanoString as a top idea after hosting management meetings. The analyst said its core business seems healthy, with SPRINT systems driving continued installed base growth, and meaningful upside is seen from companion diagnostic collaborations. Ramsay said shares are undervalued relative to its growth profile and upside potential. Ramsay reiterated her Outperform rating and $26 price target on NanoString shares.
01/20/17
COWN
01/20/17
NO CHANGE
Target $25
COWN
Outperform
NanoString price target lowered to $25 from $30 at Cowen
Cowen analyst Doug Schenkel lowered his price target on NanoString to $25 and cut his forecast to reflect the impact of its Q4 miss and lingering uncertainty. Despite the shortfall, Schenkel still believes in the company's platform and views the recent selloff as disproportionate. He believes better execution will drive the shares higher and said the company remains attractive as a standalone and strategic asset. Schenkel maintained his Outperform rating on NanoString shares.
04/20/17
MSCO
04/20/17
DOWNGRADE
MSCO
Equal Weight
NanoString downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/17
04/20/17
DOWNGRADE
Target $20

Equal Weight
NanoString downgraded on cautious survey results at Morgan Stanley
As previously reported, Morgan Stanley downgraded NanoString to Equal Weight from Overweight and lowered its price target to $20 from $23. Analyst Steve Beuchaw said expectations appear high relative to his instrument and CDx survey. The survey indicates muted expectations for instrument demand and industry discussions suggest less enthusiasm for the nCounter instrument for diagnostic applications. Beuchaw now expects growth to be 20-30% over the next three years compared to 30-40% growth over the last two years and lowered estimates and reduced his price target to $20 from $23 on shares.
LRCX Lam Research
$155.75

-0.09 (-0.06%)

07/27/17
KEYB
07/27/17
NO CHANGE
KEYB
Lam Research price target raised to $202 from $180 at KeyBanc
KeyBanc analyst Weston Twigg raised his price target on Lam after the company reported beat and raise Q2 results. The analyst says that the company's September quarter guidance was "strong," while its December quarter "should be even better." He keeps an Overweight rating on the shares.
07/27/17
NEED
07/27/17
NO CHANGE
Target $200
NEED
Buy
Lam Research price target raised to $200 from $175 at Needham
Needham analyst Y. Edwin Mok raised his price target for Lam Research to $200 from $175, citing "solid" 2H17 outlook on memory demand and strong execution. The analyst reiterates a Buy rating on the shares.
08/03/17
SBSH
08/03/17
DOWNGRADE
SBSH
Neutral
Lam Research downgraded to Neutral from Buy at Citi
Citi analyst Atif Malik downgraded Lam Research to Neutral saying he's becoming more selective in the Semiconductor Capital Equipment space. The analyst prefers stocks with "diversified sales and strong backlog appeal to smooth out" WFE volatility in the first half of 2018.
08/03/17
08/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Perform from Outperform at Oppenheimer with analyst Derek Archila saying he no longer sees a "clear path" for Teva to return to growth in a "timely manner" amid continued pricing pressure in U.S. generics. 2. Charter (CHTR) downgraded to Neutral from Buy at Guggenheim with analyst Michael Morris citing valuation and increased his price target to $400 from $370. 3. Allstate (ALL) downgraded to Hold from Buy at Deutsche Bank with analyst Joshua Shanker citing valuation. 4. Mattel (MAT) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she left a recent management meeting with a more cautious outlook for the company's performance in the second half of 2017. 5. Lam Research (LRCX) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying he's becoming more selective in the Semiconductor Capital Equipment space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TJX

TJX

$96.29

-0.44 (-0.45%)

07:40
06/22/18
06/22
07:40
06/22/18
07:40
Recommendations
TJX analyst commentary  »

TJX price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZN

Horizon Global

$7.26

-0.1 (-1.36%)

07:40
06/22/18
06/22
07:40
06/22/18
07:40
Recommendations
Horizon Global analyst commentary  »

Horizon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

$10.45

-0.2 (-1.88%)

07:40
06/22/18
06/22
07:40
06/22/18
07:40
Syndicate
Green Brick 7.1M share Secondary priced at $9.50 »

Citi, Credit Suisse and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ATU

Actuant

$29.45

0.4 (1.38%)

07:40
06/22/18
06/22
07:40
06/22/18
07:40
Conference/Events
Actuant management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

07:40
06/22/18
06/22
07:40
06/22/18
07:40
General news
Fedspeak runs quiet until next week »

Fedspeak runs quiet until…

KMX

CarMax

$71.05

-1.77 (-2.43%)

07:39
06/22/18
06/22
07:39
06/22/18
07:39
Earnings
CarMax reports Q1 EPS $1.33, consensus $1.24 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$73.94

-0.785 (-1.05%)

07:37
06/22/18
06/22
07:37
06/22/18
07:37
Downgrade
Nike rating change  »

Nike downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AYX

Alteryx

$38.63

-1.21 (-3.04%)

07:36
06/22/18
06/22
07:36
06/22/18
07:36
Initiation
Alteryx initiated  »

Alteryx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALBO

Albireo Pharma

$36.05

1.05 (3.00%)

07:36
06/22/18
06/22
07:36
06/22/18
07:36
Conference/Events
Albireo Pharma management to meet with Needham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

INTC

Intel

$52.19

-1.27 (-2.38%)

, JPM

JPMorgan

$107.52

-0.04 (-0.04%)

07:35
06/22/18
06/22
07:35
06/22/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

INTC

Intel

$52.19

-1.27 (-2.38%)

JPM

JPMorgan

$107.52

-0.04 (-0.04%)

MS

Morgan Stanley

$49.78

-0.095 (-0.19%)

PG

Procter & Gamble

$76.44

0.59 (0.78%)

LUV

Southwest

$53.15

1.16 (2.23%)

PAGS

PagSeguro Digital

$29.42

0.91 (3.19%)

COTY

Coty

$14.48

0.03 (0.21%)

HBI

Hanesbrands

$22.04

0.615 (2.87%)

SYK

Stryker

$169.81

0.21 (0.12%)

ECA

Encana

$12.19

-0.235 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

  • 13

    Jul

  • 24

    Jul

  • 26

    Jul

  • 12

    Oct

  • 22

    Jun

SRPT

Sarepta

$149.57

-4.12 (-2.68%)

07:34
06/22/18
06/22
07:34
06/22/18
07:34
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBIO

iBio

$0.95

-0.12 (-11.22%)

07:33
06/22/18
06/22
07:33
06/22/18
07:33
Syndicate
iBio raises $16M in a public offering »

The securities offered by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$462.87

-2.66 (-0.57%)

07:33
06/22/18
06/22
07:33
06/22/18
07:33
Periodicals
Chipotle will test new menu items, strategy, NY Times reports »

Chipotle is adding five…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 26

    Jul

ABBV

AbbVie

$95.55

-2.72 (-2.77%)

07:33
06/22/18
06/22
07:33
06/22/18
07:33
Recommendations
AbbVie analyst commentary  »

AbbVie most exposed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$198.83

-2.565 (-1.27%)

07:32
06/22/18
06/22
07:32
06/22/18
07:32
Conference/Events
Lear to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

, NXPI

NXP Semiconductors

$112.55

-0.42 (-0.37%)

07:31
06/22/18
06/22
07:31
06/22/18
07:31
Hot Stocks
Qualcomm extends cash offer for NXP Semiconductors to June 29 »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$58.76

-0.03 (-0.05%)

NXPI

NXP Semiconductors

$112.55

-0.42 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

, RIG

Transocean

$11.94

-0.575 (-4.60%)

07:30
06/22/18
06/22
07:30
06/22/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

FOXA

21st Century Fox

$48.34

0.24 (0.50%)

RIG

Transocean

$11.94

-0.575 (-4.60%)

CSX

CSX

$64.06

-0.81 (-1.25%)

Z

Zillow

$61.83

-2.84 (-4.39%)

KMB

Kimberly-Clark

$100.15

-1.51 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

WSC

Williams Scotsman

$12.10

-0.3 (-2.42%)

07:30
06/22/18
06/22
07:30
06/22/18
07:30
Hot Stocks
Breaking Hot Stocks news story on Williams Scotsman »

WillScot Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SENS

Senseonics

$4.96

0.1 (2.06%)

07:29
06/22/18
06/22
07:29
06/22/18
07:29
Recommendations
Senseonics analyst commentary  »

Senseonics FDA approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

CAKE

Cheesecake Factory

$59.87

2.13 (3.69%)

07:28
06/22/18
06/22
07:28
06/22/18
07:28
Downgrade
Cheesecake Factory rating change  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSC

Williams Scotsman

$12.10

-0.3 (-2.42%)

07:26
06/22/18
06/22
07:26
06/22/18
07:26
Conference/Events
Williams Scotsman to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SLNO

Soleno Therapeutics

$2.34

-0.02 (-0.85%)

07:26
06/22/18
06/22
07:26
06/22/18
07:26
Initiation
Soleno Therapeutics initiated  »

Soleno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$91.53

-1.84 (-1.97%)

07:26
06/22/18
06/22
07:26
06/22/18
07:26
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTX

Heron Therapeutics

$40.00

9.3 (30.29%)

07:25
06/22/18
06/22
07:25
06/22/18
07:25
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

KLAC

KLA-Tencor

$110.31

0.54 (0.49%)

07:24
06/22/18
06/22
07:24
06/22/18
07:24
Downgrade
KLA-Tencor rating change  »

KLA-Tencor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.